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Ruminococcin A (RumA) is a lanthipeptide with high activity against pathogenic clostridia
and is naturally produced by the strict anaerobic bacterium Ruminococcus gnavus E1,
isolated from human intestine. Cultivating R. gnavus E1 is challenging, limiting high-
quality production, further biotechnological development and therapeutic exploitation of
RumA. To supply an alternative production system, the gene encoding RumA-modifying
enzyme (RumM) and the gene encoding the unmodified precursor peptide (preRumA)
were amplified from the chromosome of R. gnavus E1 and coexpressed in Escherichia
coli. Our results show that the ruminococcin-A lanthionine synthetase RumM catalyzed
dehydration of threonine and serine residues and subsequently installed thioether
bridges into the core structure of a mutant version of preRumA (preRumA∗). These
modifications were achieved when the peptide was expressed as a fusion protein
together with green fluorescence protein (GFP), demonstrating that a larger attachment
to the N-terminus of the leader peptide does not obstruct in vivo processivity of RumM in
modifying the core peptide. The leader peptide serves as a docking sequence which the
modifying enzyme recognizes and interacts with, enabling its catalytic role. We further
investigated RumM catalysis in conjunction with the formation of complexes observed
between RumM and the chimeric GFP fusion protein. Results obtained suggested
some insights into the catalytic mechanisms of class II lanthipeptide synthetases.
Our data further indicated the presence of three thioether bridges, contradicting a
previous report whose findings ruled out the possibility of forming a third ring in
RumA. Modified preRumA∗ was activated in vitro by removing the leader peptide
using trypsin and biological activity was achieved against Bacillus subtilis ATCC 6633.
A production yield of 6 mg of pure modified preRumA∗ per liter of E. coli culture was
attained and considering the size ratio of the leader-to-core segments of preRumA∗,
this amount would generate a final yield of approximately 1–2 mg of active RumA
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when the leader peptide is removed. The yield of our system exceeds that attainable in
the natural producer by several 1000-fold. The system developed herein supplies useful
tools for product optimization and for performing in vivo peptide engineering to generate
new analogs with superior anti-infective properties.
Keywords: lanthipeptides, ruminococcin-A, biosynthesis, preRumA, expression, ribosomal peptide, antimicrobial
peptide, mass spectrometry
INTRODUCTION
The healthcare sector of our society is currently facing a
precarious situation that has been vividly described as a “new
pre-antibiotic era” where it is estimated that within the next
few years, most of the commonly used anti-infective agents
may become ineffective due to growing increase of antibiotic
resistances provoked by improper use of antibiotics in human
medication and animal farming (Rios et al., 2016). Owing to their
special structural, physicochemical and functional characteristics;
antimicrobial peptides (AMPs) of the lanthipeptides subgroup
may be employed as alternative drugs (Dischinger et al., 2014).
Lanthipeptides are a group of ribosomally synthesized peptides
characterized by the presence of thioether cross-linked amino
acids, lanthionines/methyllanthionines, leading to a polycyclic
core structure (Dischinger et al., 2009). Lanthipeptides are mostly
produced by Gram-positive bacteria and more than 100 members
have been described in the literature (Dischinger et al., 2014;
Ongey and Neubauer, 2016).
Lanthipeptide synthetases are enzymes that catalyze
posttranslational modifications (PTMs) of lanthipeptides.
Those of class II lanthipeptides are dual-functional, possessing
an N-terminal dehydratase domain and a C-terminal cyclase
domain (Repka et al., 2017). They are generally referred to as
LanM proteins (Lan is a general notation for the products of
a lanthipeptide biosynthesis cluster). As a general mechanism,
the dehydratase domain of LanM catalyzes the dehydration of
threonine residues in the core peptide to didehydrobutyrine
(Dhb), and serine residues to didehydroalanine (Dha) (Chatterjee
et al., 2005). Subsequently, the cyclase domain of LanM engages
in Michael-type addition-cyclisation reactions involving
Dhb/Dha and thiol groups of cysteines in the core structure to
generate methyllanthionine/lanthionine (MeLan/Lan) bridges
(Dabard et al., 2001). Once all the PTMs are installed, the
N-terminal domain of a dedicated bifunctional ABC-transporter
maturation and secretory (AMS) protein cleaves off the leader
peptide, consequently activating the peptide which is then
exported by the same protein to the extracellular space (Repka
et al., 2017).
We have previously shown that compared with chemical
approaches biotechnological methods are superior for the
production of lanthipeptides (Ongey and Neubauer, 2016), and
examined the beneficial effects of structural engineering on
lanthipeptide pharmacological properties that may encourage
therapeutic use (Ongey et al., 2017). It is, however, challenging to
develop a robust bioprocess with the natural isolates since most
of them like Actinoplanes spp. (Boakes et al., 2010), Actinomadura
namibiensis (Meindl et al., 2010) and Ruminococcus gnavus
(Dabard et al., 2001) produce low yields and require much efforts
and cost to cultivate.
A heterologous host like Escherichia coli has obvious
advantages including short generation time, high cell density
growth, high product yield, and ease of manipulation, which may
facilitate a variety of investigations on a target product. However,
E. coli hosts do not usually harbor the machinery necessary to
introduce the PTMs on the lanthipeptides and those are therefore
required to be supplied to them from external sources. Nagao
and colleagues isolated a gene fragment from the biosynthesis
cluster of the lantibiotic (lanthipeptide with antibacterial activity)
nukacin ISK-1, containing the genes that encode the precursor
peptide and the lanthionine synthetase, and expressed them
on a single vector in E. coli to obtain modified nukacin ISK-
1 (Nagao et al., 2005). In similar approaches several other
highly efficient lanthipeptide production systems were described
in recent years where the essential genes were successively
inserted in a single vector under the control of separate T7-
RNA polymerase promoters (Fujita et al., 2007; Caetano et al.,
2011a; Shi et al., 2011, 2012; Tang and van der Donk, 2012;
Kuthning et al., 2015). Recently, data obtained by Basi-Chipalu
and coworkers varied the concept by coexpressing the precursor
peptide and the lanthionine synthetase on separate plasmids in
E. coli to obtain modified pseudomycoicidin (Basi-Chipalu et al.,
2015), although mixtures of incomplete dehydration products
were observed.
RumA is a trypsin-regulated lantibiotic naturally produced
by R. gnavus E1 (Dabard et al., 2001; Gomez et al., 2002).
R. gnavus E1 is a strictly anaerobic Gram-positive bacterium
which was first identified in human feces (Ramare et al.,
1993). This AMP possesses high activity against pathogenic
Clostridia, making it a plausible target for the treatment of
human infections and livestock diseases, and may also be used in
food industry as preservative. Figure 1A shows the biosynthesis
genes cluster of RumA, with the three genes rumA1A2A3
coding for the same product (preRumA) – possibly an outcome
of genetic multiplication that occurred during evolution. The
other essential genes include rumM which encodes the dual-
functional lanthionine synthetase (RumM) that catalyzes PTMs
in the core peptide (Figure 1B). rumT encodes the bifunctional
AMS protein responsible for cleaving off the leader peptide
(Figure 1B) and consequently activating the modified preRumA.
The leader peptide serves as a docking motif which allows
the modifying enzyme to bind and catalyze modifications in
the core peptide, and also keeps the peptide inactive in the
producer organism (Mavaro et al., 2011; Repka et al., 2017).
Although Ramare et al. (1993) suggested that trypsin was the
activator protein, subsequent studies proved that it is actually
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FIGURE 1 | Ruminococcin-A biosynthesis genome cluster and primary structure of the precursor peptide preRumA. (A) The genetic cluster encodes rumFEGHR2,
hypothesized to confer immunity in the host, rumRK, encoding regulatory proteins, rumTX, encoding proteins involved in transport and processing, rumA1A2A3
encoding the preRumA and rumM, encoding the dual-functional lanthionine synthetase (RumM). The various catalytic domains of RumM, including active site
cofactor of the cyclase domain are indicated. (B) The peptide sequence of preRumA contains a leader peptide (position –23 to –1), the core peptide (position 1–24)
and the Gly-Gly motif (position –2/–1) where proteolytic cleavage occurs. Threonine, serine and cysteine side chains involved in thioether crosslink formation are also
indicated.
involved in the regulation of RumA biosynthesis (Gomez et al.,
2002). Additionally, although a trypsin site is present in the
core structure of RumA (Lys6), Dabard et al. (2001) showed
that trypsin does not cleave at this site due to the presence of
modifications at the adjacent threonine residue.
Expression and peptide engineering possibilities of RumA
may be limited by the strictly anaerobic nature of the
native producer and the relatively large size (12.8 kb) of the
ruminococcin-A gene cluster (Gomez et al., 2002). As reported
for the class II lanthipeptides nukacin ISK-1 (Nagao et al.,
2005) and lichenicidin (Caetano et al., 2011b), and many other
lanthipeptides (Shi et al., 2011), active expression in E. coli does
not require all the genes present in the biosynthesis cluster. This
is because most of the other genes present in the biosynthesis
cluster play accessory roles and are not directly involved in
the expression and PTMs formation process. Therefore, in
order to limit metabolic burden on a heterologous host, the
“non-essential” genes may be isolated to facilitated high-quality
production and purification. For instance, the hypothetical genes
for immunity rumFEGHR2, the bifunctional transporter rumT
and regulatory operon rumRK may not directly involved in the
biosynthesis and modifications of preRumA. Taking this into
consideration, we posited that the biosynthesis and modification
of preRumA solely requires the expression of rumA and
rumM genes. In this study, we utilized dual-vector and single-
vector approaches to engineer the pathway for biosynthesis and
modifications of preRumA in E. coli. The genes encoding the
lanthionine synthetase and the precursor peptide were amplified
from the genome of R. gnavus E1 and coexpressed in E. coli. We
show that the biosynthesis and modification of preRumA can be
successfully achieved by expressing the precursor peptide as a
cleavable fusion protein together with GFP. A simple extraction
strategy was developed to isolate the cleaved peptide and mass
spectrometry was applied to characterize the structure of the
peptide. The heterologous system developed in this study may
be applied in subsequent studies as a useful tool for optimizing
ruminoccin-A production, as well as performing in vivo peptide
engineering to improve its physicochemical and pharmacological
features or generating new analogs of the peptide with superior
anti-infective properties.
MATERIALS AND METHODS
Bacterial Strains and Cultivation
Conditions
Ruminococcus gnavus E1 cultivation was performed in an
anaerobic cabinet at 37◦C, using a pre-reduced brain heart
infusion (Difco Laboratories, Detroit, MI, United States) broth
into which 5 g of yeast extract (Difco) and 5 mg of hemin
(Sigma-Aldrich) per liter were added as supplements (Dabard
et al., 2001). E. coli Top10 was used for cloning and plasmid
storage while E. coli W3110 was used as the expression host. For
E. coli cultivations, all media were supplemented with antibiotic
concentrations of 50 µg ml−1 of kanamycin or 34 µg ml−1 of
chloramphenicol. Unless stated otherwise, E. coli and B. subtilis
ATCC 6633 cultivations were performed at 30◦C with an agitation
speed of 200 rpm. All strains used in this study are described in
Table 1.
PCR Cloning, Mutagenesis, and
Construction of Expression Vectors
For PCR, genomic DNA from R. gnavus E1 was extracted using
GenEluteTM Bacterial Genomic DNA Kit (Sigma-Aldrich).
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TABLE 1 | Description of microbial strains used in this study.
Name of strain Description Purpose Source
E. coli W3110 Wild type-like E. coli: F− λ− rp/z-I INV(rrnD, rrnE) Expression host Stock center, Yale
Ruminococcus gnavus El Wild type Isolation of genomic DNA CNRS, Marseille
B.subtilis ATCC 6633 – Biological activity assay DSM 347
E. coli Top 10 F−mcrA 1(mrr-hsdRMS-mcrBC) Φ80lacZ1M15 1lacX74
recAl araD139 1(ara leu) 7697 galU galK rpsL (StrR) endAl
nupG
Plasmid storage Invitrogen
WLEOv4 CmR, W3110 carrying pLEOrA Expression of His6-preRumA This work
WLEOrM’ CmR, W3110 carrying pLEOrM’ Expression of His6-RumM This work
WLEOrMi CmR, W3110 carrying pLEOrM1 Expression of His6-RumM This work
WLEOM/M KanR, CmR, W3110 carrying pLEOrA and pLEOrM Coexpression of His6-preRumA and His6-RumM on
separate plasmid
This work
WLEOgrv4 CmR, W3110 carrying pLEOgrA Expression of His6-GFP-TEV-preRumA This work
WLEOgrv4/M KanR, CmR, W3110 carrying pLEOgrA and pLEOM Coexpression of His6-GFP-TEV-preRumA and
His6-RumM on separate plasmid
This work
WLEOgr.4∗ CmR, W3110 carrying pLEOgrA∗ Expression of His6-GFP-TEV-preRumA∗ This work
WLEOgrA∗Ml CmR, W3110 carrying pLEOgrA∗M1 Coexpression of His6-GFP-TEV-preRumA∗ and
His6-RumM on the same plasmid
This work
WLEOsrA∗ CmR, W3110 carrying pLEOsrA∗ Expression of His6-SUMO-preRumA∗ This work
WLEOsrA∗M CmR, W3110 carrying pLEOsrA∗M Coexpression of His6-SUMO-preRumA∗ and
His6-RumM on the same plasmid
This work
Phusion R© and Q5 R© High-Fidelity DNA polymerases were
purchased from New England Biolabs (NEB) (Frankfurt
am Main, Germany). Oligonucleotides (Supplementary
Table S1) were purchased from TIB MOLBIOL (Berlin,
Germany). For isolation and storage purposes, the primer
pair rumClus_f/rumClus_r was used to amplify a segment
of the ruminococcin-A gene cluster (GenBank accession no.
AF320327), containing rumA1A2A3 and rumM. The blunt-
ended amplicons were directly inserted into a SmaI-restricted
pCTUT7 vector to yield pLEOrC2 (Supplementary Figure S1).
The pCTUT7 vector belongs to a library of 45 plasmids derived
from pKA100 (Krebber et al., 1996, 1997) and designed for
optimizing recombinant protein expression in E. coli (Kraft et al.,
2007). The main features of these vectors are; a lacUV5-based
promoter system (designated as CTU), possessing a mutation in
the catabolite activator protein (CAP) site, lacUV5 sequence of
the original pAK100, −35 region from tac promoter, ribosomal
binding site (RBS) of gene 10 of bacteriophage T7 (T7 RBS),
the lac repressor gene and a chloramphenicol resistance gene
(Kraft et al., 2007). Specific plasmids from this library were
used recently to obtain high yield of the non-ribosomal peptide
valinomycin in E. coli W3110 (Jaitzig et al., 2013; Li et al.,
2014), showing that the system is efficient for the production of
difficult-to-express proteins.
For the expression of the precursor peptide preRumA,
PCR was performed with primer pair rumA_f/rumA_r and
pLEOrC2 as template. The resulting rumA1 PCR product was
digested with NheI and PstI FastDigest enzymes (Thermo
Scientific, Darmstadt, Germany) and ligated into NheI/PstI-
digested pCTUT7 vector yielding pLEOrA. For the expression
of ruminococcin-A lanthionine synthetase RumM, PCRs with
primer pairs rumM_f2/rumM_r and rumM_f3/rumM_r using
pLEOrC2 as template were performed, and the resulting
amplicons were digested with NheI/PstI and BamHI/PstI, and
further ligated into the pCTUT7 and pJL10 expression vectors
generating pLEOrM’ and pLEOrM, respectively. The pJL10
plasmid is a modification of commercial plasmid pRSF-1b where
the T7 promoter system was replaced with the CU promoter
(Li et al., 2015). The promoter designated CU is also a lacUV5-
based and was obtained from the library created by Kraft et al.
(2007). Additional features on the plasmid include a kanamycin
resistance gene, RSF 1030 origin of replication and the lac
repressor gene.
To replace the RBS sequence (TAACGAGGGCAACAT) of
the promoter/RBS region of pJL10 plasmid hosting the CU
promoter, with that of the T7 RBS (GAAGGAGATATACAT), the
restriction enzymes SpeI and NdeI were used to remove the lacI
gene and the CTU promoter from the pCTUT7 vector. Primer
pair SDT7_f/SDT7_r was used to amplify the lacI gene together
with the CU promoter from the pJL10 vector. The resulting
amplicons were digested with SpeI and NdeI and subsequently
cloned into the backbone of the previously digested pCTUT7 to
yield pCUT7. NheI/PstI-digested rumM amplicons were inserted
into NheI/PstI-restricted pCUT7 vector to yield pLEOrM1.
PCR, using pLEOrA as template together with the Q5 R© Site-
Directed Mutagenesis Kit (NEB) and the pTrypsin_f/pTrypsin_r
primer pair were employed to replace the Gly residue at position
−1 of preRumA with Arg to yield the pLEOrA∗ plasmid.
To fuse preRumA or preRumA∗ to green fluorescence
protein (GFP), two special primers rumAs_f and gfps_r
were designed such that their 5′ overhangs had partially
complementary regions. gfpmut-2 was amplified from pUA66
plasmid (Zaslaver et al., 2004) using primer pair gfp_f /gfps_r
while rumA or rumA∗ was amplified from pLEOrA or pLEOrA∗
using primer pair rumAs_f /rumA_r. A TEV protease cleavage
site (GAAAACCTGTATTTTCAGGGC) was also inserted in
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between gfpmut-2 and rumA. The final fusion fragment obtained
via overlap extension PCR (Horton et al., 1990) was digested
withNheI/PstI and ligated into correspondingNheI/PstI-digested
pCTUT7 to yield pLEOgrA or pLEOgrA∗. To fuse preRumA∗
to small ubiquitin-like modifier (SUMO), NheI/PstI-digested
rumA∗ PCR product amplified from pLEOrA∗ was inserted into
NheI/PstI-digested pCTUT7-SUMO plasmid to yield pLEOsrA∗.
To clone the genes encoding the precursor peptide and the
modifying enzyme successively on the same plasmid, primer
pair prumM_f/prumM_r was used to amplify a cassette from
pLEOrM1 containing the CU promoter, T7 RBS and rumM.
The resulting amplicons were digested with PstI and HindIII
and subsequently inserted into PstI/HindIII-digested pLEOgrA∗
to generate pLEOgrA∗M1. In the same manner, rumM was
amplified from pLEOrM and inserted into pLEOsrA∗ to yield
pLEOsrA∗M. The sequences of all resultant plasmids and mutants
were verified by sequencing.
Transformation, Growth and Protein
Expression
To achieve expression of the designated genes, pLEOrA and
pLEOgrAwere cotransformed with pLEOrM in electrocompetent
E. coli W3110 cells resulting in expression strain WLEOrA/M and
WLEOgrA/M, respectively. In a similar manner, pLEOgrA∗M1
and pLEOsrA∗M were transformed to yield the strains
WLEOgrA∗M1 and WLEOsrA∗M, respectively. Additionally,
pLEOrA, pLEOgrA, pLEOgrA∗, pLEOsrA∗, pLEOrM’, and
pLEOrM1 were separately transformed into E. coli W3110
yielding WLEOrA, WLEOgrA, WLEOgrA∗, WLEOsrA∗,
WLEOrM’, and WLEOrM1 strains, respectively (Table 1).
Growth optimization and expression tests were performed in
24 deep-well plates using the EnPresso R© B growth system
(Enpresso GmbH, Berlin, Germany) according to the
manufacturer’s recommended procedure. At the point of
induction, 3 ml of respective cultures were split into the 24-well
deep-well plates and induced with varying concentrations of
IPTG inducer. Cells were cultivated for further 18–24 h while
measuring the optical densities at different time points. At the
end of cultivation, cells were collected in 2 ml Eppendorf tubes
by centrifuging for 1 min at 16,000 × g at 4◦C. Larger cultures
were cultivated in freshly prepared terrific broth (TB) medium
by supplying appropriate concentrations of required antibiotics
to 1 l of culture. The cells were induced with 100 µM IPTG
(optimized from micro-scale cultivations) at OD600 between 0.8
and 1, and further cultivated for 18–24 h. Cells were collected
by centrifugation for 10 min at 6000 × g at 4◦C. The cell pellets
were stored at−20◦C for further preparations and analysis.
Purification, TEV Cleavage and
Extraction
Cell pellets from −20◦C were thawed and resuspended in
lysis buffer (50 mM NaH2PO4·H2O, pH 8, 300 mM, 10 mM
Imidazole). Sonication was applied to disrupt cells and release
proteins. Cell debris was separated from the soluble lysate by
centrifugation for 15 min at 16,000 × g at 4◦C. The clarified
lysates were applied to His SpinTrap columns (GE Healthcare,
United Kingdom) for expression/purification screening. Larger
purifications were performed with the ÄKTA Avant 25
instrument by loading the clarified bacterial lysates onto a 1-ml
HisTrap FF Crude column (all from GE Healthcare) and eluted
by applying a gradient range of 0–100% of elution buffer (50 mM
NaH2PO4·H2O pH 8, 300 mM NaCl, 500 mM imidazole).
Purified His6-RumM was concentrated using Amicon Ultra
centrifugation tubes with 100 kDa molecular weight cut-off
(Merk Millipore, Darmstadt) while His6-GFP-TEV-RumA∗ was
concentrated using a 30-kDa cut-off tube. Protein concentrations
were measured using the Bradford Coomassie brilliant blue dye
method (Bradford, 1976). The IMAC concentrated sample was
subsequently injected onto a HiLoad 16/60 Superdex pg 200
column (GE Healthcare) and eluted with the gel filtration buffer
(20 mM NaH2PO4·H2O pH 8, 150 mM NaCl, 10% glycerol).
Fractions were pooled, concentrated and measured using the
Bradford assay, aliquoted and stored at−20◦C.
Before TEV cleavage the samples from −20◦C were thawed
on ice, and 1 mM DTT and 0.5 mM EDTA were added.
One Hundred microgram of fresh homemade TEV protease
was added to 1 mg of protein and then incubated overnight
at 4◦C. TEV-digested samples were further purified using a
Ni2+-NTA column and collecting the eluent containing the
desired product. The eluent was then dialyzed in water and
dried using a Concentrator Plus vacuum (Eppendorf, Hamburg,
Germany) and stored at−20◦C for further use. Alternatively, the
TEV-digested samples were extracted with 1-butanol by adding
one volume of the solvent and stirring the mixture at room
temperature for 1–2 h. Extracts were separated by centrifugation
for 5 min at 3000 × g. The upper organic layer containing the
peptides was obtained and protein concentrations were measured
using the NanoDrop. Recovered peptide extracts were dried and
stored at−20◦C for subsequent applications.
SDS-PAGE and Native PAGE Analyses
For sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE), larger proteins were processed with 10% gels using
standard protocols (Sambrook and Russell, 2001) while smaller
peptides were analyzed using 16% Tricine PAGE as described
elsewhere (Schägger, 2006). For native PAGE, samples, buffers
and gel recipes were assembled following the same procedure as
described for standard SDS-PAGE except that detergents (SDS
and urea), DTT and sample heating step (95◦C, 5 min) were not
included. Eight percent resolving, with 4% stacking gels were used
for the native PAGE analysis. All gels were visualized by staining
with colloidal blue silver Coomassie G-250 as reported elsewhere
(Candiano et al., 2004).
Automated Fluorescence Measurements
Qualitatively, target product expressions in WLEOgrA∗
and WLEOgrA∗M1 were estimated by measuring the GFP
fluorescence signal intensities. The strains were cultivated in 24-
well round-bottom plates at 30◦C, and the relative fluorescence
emission of the cells was measured using a SynergyTM Mx
monochromator-based multimode microplate reader (BioTek
Instruments, Winooski, Vermont, United States). Time-course
GFP fluorescence signal intensities were measured and recorded
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as relative fluorescent unit (RFU) every 10 min at 528 nm for
15–30 h. As a control the auto-fluorescence of a strain which
does not express GFP was also recorded in the same manner.
Mass-Spectrometric Analyses of
preRumA∗
For peptide identification, pieces were excised from SDS-PAGE
gels and digested with an in-gel tryptic digestion protocol
(Shevchenko et al., 2006). Dried samples were redissolved in 0.1%
formic acid. Both the tryptic digest and resolubilized samples
were desalted and concentrated using C18-ZipTips (Merck,
Darmstadt, Germany). When desired, the ZipTip procedure
was also applied directly to the purified TEV-digested samples.
Processed samples were directly injected into an LTQ Orbitrap
XL Hybrid Ion Trap-Orbitrap mass spectrometer or nanoLC-
coupled Thermo Orbitrap Fusion mass spectrometer (Thermo
Fisher Scientific), both with a nanoelectrospray ion source. For
the LTQ-Orbitrap, highly intense ions identified in the full
MS were directed to the orbitrap analyzer where they were
fragmented and processed in the linear ion trap. For the Thermo
Orbitrap Fusion, specific ions were selected and channeled to the
ion-routing multipole where they were fragmented, processed in
the C-trap and analyzed by the orbitrap mass analyzer.
For the liquid chromatography-electrospray ionization-mass
spectrometry (LC-ESI-MS) analyses, the dried extracts were
dissolved in acetonitrile (ACN)/H2O/formic acid (50:50:0.2%).
Five microliter were introduced into an Agilent 1290 Infinity
HPLC system (Agilent Technologies, Waldbronn, Germany),
followed by an ESI-Triple-Quadrupole LC-MS 6460 electron
spray ionization mass spectrometry analysis using multiple
reaction monitoring. The material used for the column and pre-
column was Poroshell 120 EC-C8 (2.1 × 50 mm, 2.1 µm).
Solvent A of the HPLC system corresponded to H2O while
ACN was designated as solvent B. The introduced sample was
eluted with an ACN gradient from 5 to 20% solvent B within
0.5 min, followed by 70% B in 4 min and then to 100% B in
0.2 min. An isocratic elution with 100% B was finally applied
for 1.3 min. The flow rate was set at 0.7 ml min−1. Xcalibur
(Thermo Fisher Scientific), MaxQuant (Cox and Mann, 2008)
and Xi Spectrum Viewer1 were used for data analysis. MASCOT
search engine (Matrix Science, United Kingdom) was used for
sequence identification by searching the MS and MS/MS data.
Iodoacetamide Derivatization and
Trypsin Digestion
Dried extracts were dissolved in 100 mM ammonium bicarbonate
to obtain≈0.5–1 mg ml−1 of soluble peptide. DTT was added to
30 µl of the soluble peptide to a final concentration of 10 mM.
The mixture was incubated at 55◦C for 1 h. Four hundred
millimolar Iodoacetamide (Sigma) (freshly dissolved in 100 mM
ammonium bicarbonate) was added to the sample to a final
concentration of 25 mM and incubated at room temperature for
45 min in the dark. Six point three microliter of 0.1µgµl−1 mass
spectrometry grade trypsin (Promega, Lyon, France) solution was
1http://spectrumviewer.org/
added to the derivatized sample and incubated on a shaking
platform at 37◦C overnight. The samples were purified using C18-
ZipTip and analyzed as described earlier. For the modified and
non-modified His6-SUMO-preRumA∗, the derivatization step
was not performed. The purified samples in elution buffer 2
(20 mM TRIS-HCl, pH 8, 250 mM NaCl, 300 mM imidazole)
were first dialyzed in water and further buffer-exchanged in
100 mM ammonium bicarbonate buffer. Fifteen microliter of
trypsin stock solution (0.1 µg µl−1) was added to 100 µl of
samples obtained from each of the modified and non-modified
His6-SUMO-preRumA∗ and incubated on a shaking platform at
37◦C overnight. The whole tryptic digests were used for SDS-
PAGE and bioassay analyses.
Biological Assay
Bacillus subtilis ATCC 6633 is one of the indicator strains for
RumA as reported by Dabard et al. (2001). The strain was
cultivated in a medium composed of peptone (5.0 g l−1), meat
extract (3.0 g l−1) and MnSO4 (0.02 g l−1) and then spread on
bacteriological agar plates (1.5% agar) containing punched wells.
The plates were kept under the clean bench for about 15 min
to allow excess media to evaporate and 50 µl of each digested
sample were pipetted into separate wells and incubated at 30◦C
overnight.
RESULTS
Construction of Vectors for E. coli
Expression of preRumA
The genes rumA and rumM were transferred to an E. coli host
on individual plasmids with compatible origins of replication.
rumM was encoded in three different plasmid versions pLEOrM,
pLEOM1, and pLEOM1 together with a His-tag (His6-RumM).
rumA was also encoded in three different plasmid versions
pLEOrA (encoding His6-preRumA), pLEOsrA∗ (encoding His6-
SUMO-preRumA∗) in which SUMO was fused to the N-terminus
of preRumA∗, pLEOgrA (encoding His6-GFP-TEV-preRumA)
and pLEOgrA∗ (encoding His6-GFP-TEV-preRumA∗). The latter
two constructs contained GFP which was linked to the precursor
peptide via a TEV cleavage site. Note here that the symbol
(∗) denotes the variant containing trypsin cleavage site at
position -1 of preRumA which was generated by replacing Gly-
1 with Arg. For clarity, this mutant is referred to as preRumA∗
while the wild-type remains preRumA throughout this report.
Additionally, plasmid versions encoding a bicistronic operon
pLEOgrA∗M1 (expressing both His6-RumM and His6-GFP-
TEV-preRumA∗) and pLEOsrA∗M (expressing both His6-RumM
and His6-SUMO-preRumA∗) were also generated. The plasmids
containing the two rumA variants and rumM were traceable via
different antibiotic resistance genes.
Our cloning approach employed the use of conventional
restriction enzymes and ligation to insert the specific genes of
interest under the control of IPTG-inducible promoters. Two
main promoter systems were employed: the IPTG-inducible CTU
and CU promoters which are based on the lacUV5 promoter
system (Kraft et al., 2007). The vector that hosted the CTU
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promoter was based on pKA100 (Krebber et al., 1996) and
pDest15 and possessed mutation in the CAP site, lacUV5
sequence of the original pAK100,−35 region from tac promoter,
T7 RBS and a recombination cassette amplified from pDest15
(Kraft et al., 2007). Additionally, the plasmid that hosted the
CU promoter (pJL10) was a modification of pRSF-1b where the
strong T7 promoter was substituted for the CU promoter (Li
et al., 2015). The difference between the CTU (stronger) and CU
(relatively weaker) promoters were specific mutations at their
respective −35 regions and RBS (Kraft et al., 2007). The plasmid
maps of the resultant expression vectors used in this study are
described in (Supplementary Figure S2).
Expression of His6-preRumA and
His6-GFP-TEV-preRumA(∗) Constructs
Expressing His6-preRumA alone (i.e., applying the strain
WLEOrA) did not produce any soluble product. His6-preRumA
was largely present in the insoluble fraction (Figure 2A),
suggesting that the his-tagged precursor peptide must have
aggregated or formed inclusion bodies as reported for other
lantipeptide precursors expressed in the absence of the PTMs
enzyme (Li et al., 2009, 2010). Nevertheless, when His6-
preRumA was coexpressed with His6-RumM, SDS-PAGE
analyses of extract from the strain WLEOrA/M indicated soluble
expression of both His6-RumM (Figure 2B) and His6-preRumA
(Figure 2C). Excised SDS-PAGE bands representing His6-
preRumA and His6-RumM were subjected to in-gel tryptic
digestion and analyzed using an Orbitrap-coupled HPLC system.
Subsequent MASCOT search of the MS and MS2 data from
orbitrap analyzer identified the preRumA peptide sequence
(UniProt ID: P83674) as well as RumM sequence (UniProt
ID: Q9L3F1). No modification was identified in His6-preRumA
extracted from strain WLEOrA/M. Furthermore, MS2 data
of tryptic digest of the His6-preRumA did not provide any
supporting evidence to suggest that the precursor peptide was
modified in the two-vector system (Figure 2D), even though
expression of RumM was visibly apparent.
Since we did not achieve modifications of preRumA by
coexpressing His6-preRumA simultaneously with RumM, and
considering the fact that the small precursor peptide once
expressed may encounter diverse physical and biochemical
challenges prior to PTMs formation by RumM, we decided to
provide a physical support by fusing GFP to its N-terminus
via a TEV cleavage site as described in the experimental
part. This was done to enable solubility and stability of the
precursor peptide. Expressing the resulting chimeric construct
encoding the His6-GFP-TEV-preRumA alone or coexpressing
in the presence of low levels of RumM, encountered some
degradation issues (Supplementary Figure S3) as described in
Supplementary Information section “Fusion of preRumA to GFP,
Expression and LC-ESI-MS Analyses.” A mixture of partially
modified, fully modified and non-modified preRumA were
identified in butanol extracts of TEV-digested His6-GFP-TEV-
preRumA from strain WLEOgrAM. The latter outcome led
us to posit that the preRumA/RumM ratio was not optimal
for full modifications to occur. Hence, we optimized the
expression constructs and the host vectors to enhance soluble
overexpression of preRumA and RumM as an approach to
limit the degradation and improve production quality and
quantity.
Initially, we substituted Gly-1 in preRumA for arginine
to enable trypsin cleavage at that position and consequent
activation of the peptide. Fusing this variant to GFP resulted in
a construct encoding His6-GFP-TEV-preRumA∗. Furthermore,
the chimeric construct together with the gene encoding His6-
RumM were hosted in the same operon, generating a single-
plasmid bicistronic expression vector named pLEOgrA∗M1. In
the bicistronic operon, expression of His6-GFP-TEV-preRumA∗
was controlled by the CTU promoter and T7 RBS. Expression of
His6-RumM was enhanced by changing the RBS from the lactose
operon (that was originally used together with the CU promoter)
to T7 RBS. This implies that RumM expression was regulated by
the combination of the CU promoter and the RBS of gene 10 of
bacteriophage T7.
To assess the strength of the different promoter arrangements,
strains WLEOrM1 (producing His6-RumM under control of
CU promoter) and WLEOrM’ (producing His6-RumM under
control of CTU promoter) were grown in TB medium as
described in the experimental part except for the fact that
the 100-ml culture was distributed into 24-well deep-well
plate at the point of induction. Varying IPTG concentrations
were applied to one row of the wells and then replicated
for the remaining three rows. ODs of the cultures were
measured at different time points. Results in Figures 3A,B
show that both strains shared similar growth characteristics.
His6-RumM production was drastically improved in strain
WLEOrM1 compared to strain WLEOrM’ (Figure 3C). Since
there was no significant influence on growth for both
plasmids, we can only conclude that the CU promoter and
T7 RBS combination favored expression of His6-RumM. It
is important to also state that although the combination of
CTU promoter and T7 RBS is considered the strongest in
that series (Kraft et al., 2007), His6-RumM expression was
still low (i.e., applying pLEOrM’ expression vector). However,
combining the CU promoter and T7 RBS (i.e., applying
pLEOrM1 expression vector) intensified RumM expression.
Furthermore, the truncation issues encountered when His6-GFP-
TEV-preRumA was expressed without or with low levels of
RumM was resolved by applying the pLEOgrA∗M1 expression
vector as seen below.
The E. coli W3110 strain transformed with the pLEOgrA∗M1
vector named strain WLEOgrA∗M1 was cultivated in TB medium
induced with 200 µM IPTG. The cells grew exponentially to a
final OD600 of∼15 after 32 h of cultivation (Figure 4A). The GFP
fluorescence signals of WLEOgrA∗M1 increased constantly over
the entire cultivation period while the control strain WLEOrM’
(expressing His6-RumM alone) remained relatively constant
(Figure 4B). Desired proteins from strain WLEOgrA∗M1
lysate were purified using IMAC, followed by size exclusion
chromatography. Äkta chromatograms depicting the IMAC
and size exclusion chromatographic elutions of His6-RumM
and His6-GFP-TEV-preRumA∗ are shown in Figures 4C,D,
respectively. Purification yields are presented in Table 2. It
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FIGURE 2 | Expression test and MS2-ESI-Orbitrap spectrum of gel-extracted His6-preRumA. (A) SDS-PAGE analysis of purified soluble (lane 1) and insoluble (lane
2) His6-preRumA produced in the absence of RumM (i.e., extracts from strain WLEOrA). (B) Analysis of purified control extracts from strain WLEOrA (Lane 1) and
extracts from strain WLEOrA/M, showing soluble production of His6-RumM (Lane 2). (C) Soluble His6-preRumA extracted from strain WLEOrA/M (Lanes 1 and 2).
(D) Complete fragmentation of His6-preRumA, following tryptic digestion. None of the precursor ions resulting from the LC-MS analysis of the tryptic digest indicated
fragmentation restrictions at the positions where thioether cross-bridges were expected to be formed. Consequently, there was no ring structure in the product
measured. cm, carbamidomethylation; ox, oxidation. Full scans of sliced gel pieces in A, B and C are presented in Supplementary Figure S9.
was surprising to observe that from the optimized strain,
His6-RumM and His6-GFP-TEV-preRumA∗ despite their size
difference (∼70 kDa) coeluted together and appeared as a single
peak on the size exclusion chromatogram (peak A′, Figure 4D),
which was further confirmed by SDS-PAGE (Figure 4E, lane
A′). Additionally, individual fractions that constituted the
chromatographic peak A′ were analyzed via SDS-PAGE and
results also supported this finding (Supplementary Figure S5A).
This observation was further investigated by native PAGE
(described later). Moreover, pooled fractions from elution peaks
B′ produced a single band on SDS-PAGE corresponding to
the molecular sizes of His6-GFP-TEV-preRumA∗ (Figure 4E,
lane B′).
E. coli Extraction and nLC-ESI-MS of
preRumA∗
His6-GFP-TEV-preRumA∗ construct purified from
WLEOgrA∗M1 was digested with TEV protease (see
Supplementary Figure S5B for SDS-PAGE analysis). One
half of the digested product was extracted with butanol;
the other half was run through a Ni2+-NTA column to
remove the His6-GFP-TEV fragment and other accompanying
impurities. The flow-through was collected and dialyzed in
water. Both samples were dried using a vacuum concentrator.
The mass spectrum of the butanol extract obtained from an
Orbitrap Fusion nLC-ESI-MS analysis indicated a fourfold
dehydrated product (Figure 5A) while the mass spectrum
of IMAC flow-through extracts (processed and analyzed in
the same manner) showed a mixture of fourfold dehydrated
preRumA∗ and traces of threefold dehydrated version of the
same peptide (Figure 5B). The measured m/z of preRumA∗
was consistent with the calculated m/z value of 1089.72 for
the quintuple-charged ion (M-4H2O+5H)5+ resulting from
a fourfold dehydrated preRumA∗. The mass accuracies for
all MS measurements expressed in parts per million (ppm)
are recorded in (Supplementary Table S2). The results here
suggest that the dehydratase domain of the coexpressed RumM
successfully catalyzed modifications of preRumA∗, associated
with a mass loss of four water molecules. Comparison with the
literature suggests, that these dehydrations could have occurred
at Thr7, Thr16, and Thr22 to yield three Dhb, and Ser9 to
produce one Dha. These results in corroboration with those
discussed in Supplementary Information section “Purification
and TEV Cleavage of preRumA∗,” supplied evidence that in vivo
biosynthesis and modification of preRumA∗ is achievable in
E. coli.
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FIGURE 3 | Growth and product optimization. Growth curves of strain WLEOrM1 (A) and strain WLEOrM’ (B) cultures induced with varying IPTG concentrations in
TB. (C) Expression of His6-RumM in pCTUT7 (strain WLEOrM’) versus pCUT7 (strain WLEOrM1). The concentrations of IPTG are indicated in the plots and at the
top of each lane on the gel. The optimal IPTG concentration range is 50–100 µM.
We observed that butanol extraction isolated only the fourfold
dehydrated product as traces of triple-dehydrated preRumA∗
could be found in the flow-through extract but not in the butanol.
However, the aqueous phase of the butanol extract was purified
using a C18 pipette tip and analyzed by mass spectrometry.
Results in Figure 5C indicate that butanol extraction only
isolated a fraction of the fully modified peptide since traces
of triple dehydrated products were visibly apparent in the
mass spectrum of the aqueous phase extract. Furthermore
applying direct C18-ZipTip purification of the crude TEV digest
also produced a mixture of the two species (Figure 5D).
Fully dehydrated preRumA∗ is schematically represented in
Figure 5E.
Mass-Spectrometric Fragmentation
Analysis of preRumA∗
After demonstrating that the dehydratase domain of RumM
can catalyze dehydration of the peptide, subsequent mass-
spectrometric experiments were performed to demonstrate the
activity of the cyclase domain. The cyclisation reactions introduce
thioether cross bridges between dehydrated Thr/Ser residues
and the sulfhydryl groups of specified cysteine residues. Such
information cannot be derived from the exact masses alone
because the dehydrated linear peptide (with no thioether rings)
and the cyclic forms (with thioether rings) have identical masses,
with a resultant average molecular mass of 5444.27 Da. Although
the possibility to digest with trypsin at position−1 exist, MS2 data
from trypsin digests are not discussed since we obtained better
fragmentation data with the full-length peptide.
The combination of collision-induced dissociation (CID),
higher-energy collisional dissociation (HCD) and electron
transfer dissociation (ETD) at different fragmentation voltages
produced different fragmentation pattern (Supplementary Figure
S6). The N-terminal leader sequence exhibited b- and y-type ions
with higher intensities which nicely fitted to the first 19 residues
of the leader peptide (Supplementary Figure S7). Although no
intensive b- and y-type ions were visible at the C-terminus,
intensive ion series representing fragments corresponding to
a successive loss of internal amino acid residues from the
C-terminal region were observed (Figures 6A,B). These data
demonstrate the successive loss of residues 21–16, 11–10, and
residue eight of the core peptide (See Figure 7 and the next
paragraph). Note that in assigning the product ion peaks the
following notations were considered: Cn denotes the core peptide
residue (C) at specific position (n); while Cn−n ′ denotes core
peptide residues from position n to position n′ following a C- to
N-terminal direction. No further intensive fragment ions within
the core peptide were identified. This data was consistent with
those obtained by Dabard and colleagues, however, fragment ions
resulting from the double cleavage at the amino and carboxyl
termini of Ile8, His10, and Glu11 altered our understanding
of the structural features of fully modified RumA. These ions
retained information for all other residues in the peptide
sequence even after the residues mentioned were cleaved-off
during the fragmentation process. This data demonstrated that
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FIGURE 4 | Expression and purification of His6-GFP-TEV-preRumA fusion constructs. (A) Growth profile of WLEOgrA∗M1 in TB medium. (B) GFP fluorescence
signals of the WLEOgrA∗M1 strain together with that of WLEOrM’ (expressing His6-RumM only). (C) Chromatogram showing IMAC purification of extract from
WLEOgrA∗M1. (D) Size exclusion chromatograms showing elution of injected IMAC Ni2+-NTA sample. The absorption peak of GFP is observed at 484 nm.
(E) SDS-PAGE analyses of the elution peaks. The letter atop gel represent; P, purified His6-RumM; E, A′ and B′ are pooled fractions obtained from respective peaks
labeled in (C,D).
bonds other than the peptide bonds were responsible for holding
the two adjacent fragments together. This was surprising because
data from previous characterization of RumA by Dabard and
colleagues did not show this (Dabard et al., 2001). From the
data in hand, the structure of modified preRumA∗ may be
schematically represented as shown in Figure 6C.
To further expatiate on the structural description of the
various fragments that gave rise to the intensive product ion
peaks identified in the mass spectrum, different structures were
proposed of which those presented in Figure 7 fitted precisely
to the measured m/z. Notice that each structure represent an
internal double cleavage of the polypeptide backbone from the
C-terminus that resulted in product ions associated with the
successive loss of amino acids in the direction indicated by
the arrow. Any loss of an internal residue should automatically
result in b- and/or y-type ion(s) or other associated ion
types like a, c, x, and z. Such was not the case observed
with the fragmentation of C-terminal preRumA∗. Not even
the x- and z-type ions which are observed during de novo
peptide sequencing were identified. Instead, the double cleavage
fragments hosted residues present upstream and downstream of
the cleavage position. This is only possible if there is a bond
linking the C-terminal fragment to the N-terminal segment.
The presence of cysteine or Dhb/Dha residue adjacent to these
cleavage positions allowed us to allocate thioether cross-linkages.
Moreover, Figure 7 shows details of how the various structures
were associated to their respective molecular masses, with very
high precisions.
Iodoacetamide Derivatization and
Trypsin Digestion of preRumA∗
Experiments here were designed to demonstrate that the cysteine
residues in the core peptide of preRumA∗ were involved in
the thioether ring formation and to determine whether or not
trypsin can cleave preRumA∗ at the carboxyl terminus of Lys6.
Our approach here included an iodoacetamide derivatization
step followed by an overnight trypsin digestion at 37◦C. The
iodoacetamide reaction was required to determine if the three
cysteine residues present in the core peptide had free sulfhydryl
side chains. As described in Figure 8A, the thiol group of
cysteine undergoes an irreversible reaction with iodoacetamide
to produce an alkylated species with a consequent mass shift of
+57 Da in the mass spectrum. Interestingly, no charged ionic
species was identified with a mass shifts associated to mono-,
double-, or triple- carbamidomethylation of the full length nor
other fragments labeled in Figure 8B.
Assuming that preRumA∗ did not contain any Lan/MeLan
rings, all three or at least one of the cysteine side chains in the
core peptide would have been S-carbamidomethylated. This data
supplied additional evidence to demonstrate that the sulfhydryl
groups of all three cysteine residues in the core peptide were
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TABLE 2 | Purification yields of total protein per liter.
Purification step His6-GFP-TEV-
preRumA (mg)
His6-GFP-TEV-
preRumA∗ (mg)
¤His6-GFP-TEV-
preRumA∗ (mg)
mpreRumA (mg) ∗(mg) ¤preRumA∗ (mg)
IMAC 84.53 97.61 97.61 – – –
Size exclusion 65.32 39.01 79.40 – – –
TEV-digested IMAC FT – – – 3.23 4.45 6.14
TEV-digested butanol extract – – – 1.34 2.50 4.75
The symbol ¤, pooled fractions from peaks A′ and B′ of Figure 4D. This specifically applies to His6-GFP-TEV-preRumA∗ which appeared in two separate chromatographic
peaks during purification. FT, flow-through. Concentrations were determined using the Bradford and the NanoDrop techniques.
not accessible to the alkylation reaction. Thus all the thiols must
have been protected via an alternative reaction. It is therefore
reasonable to say that the cysteinyl thiols were involved in the
cyclization step of the biosynthesis pathway which rendered them
unavailable for any further reaction with iodoacetamide. This
was not the case for unmodified His6-preRumA discussed earlier,
where all the cysteine residues were alkylated (Figure 2D).
Conversely, charged ion species representing specific
fragments belonging to the leader sequence as well as full-length
core peptide (RumA) were identified (Figure 8C). The fact
that we were not able to identify fragments pertaining cleavage
at Lys6 of the core peptide indicated that this position was
not accessible to trypsin. This data supports the findings of
Dabard et al. (2001) who showed that PTMs at Thr7 forbid
the possibility of trypsin cleavage at the adjacent Lys6 residue.
Furthermore, fragmentation of the RumA precursor ion yielded
a product ion spectrum with very little information due to low
concentration. However, we were able to deduce that some major
peaks in the spectrum carried the same information as reported
for MS2 of the full length species (Figure 8D).
Interactions Between His6-RumM and
His6-GFP-TEV-preRumA∗
As shown earlier, His6-RumM and His6-GFP-TEV-preRumA∗
were coeluted together during size exclusion chromatographic
FIGURE 5 | Extraction of preRumA∗ from TEV-digested His6-GFP-TEV-preRumA∗ produced in E. coli and nLC-ESI-MS analyses. (A) EIS-MS spectrum of butanol
extract of TEV-digested His6-GFP-TEV-RumA∗. (B) EIS-MS spectrum of flow-through obtained from TEV-digested His6-GFP-TEV-Rum∗A followed by IMAC
Ni2+-NTA column run. (C) Aqueous phase of butanol extract. (D) Direct C18-ZipTip purification of crude His6-GFP-TEV-preRumA∗ TEV digest. (E) Schematic
structure of fully dehydrated core peptide of preRumA∗. Gly-24 is added to the N-terminus of the peptide after TEV cleavage. Gly-1 in the wild-type preRumA was
substituted for Arg to enable trypsin cleavage. (M+5H)5+ = 1104.12.
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FIGURE 6 | Tandem MS2-experiments and assignment of preRumA∗ fragment ion peaks. (A) and (B) nLC-MS2 spectra representing ion series with intensive peaks
produced as a result of the fragmentation of the C-terminus of preRumA∗ core peptide. (M’+5H)5+ = 1089.72 RumA∗. A detailed description of the mass spectra is
presented in Figure 7. (C) Schematic representation of the structure of modified preRumA∗; showing the mersacidin-lipid II-binding motif.
purification despite the huge size difference between the two.
We obtained samples from the pooled fractions of representative
chromatographic peaks (Figure 4D, peaks A′ and B′) and
subjected them to TEV digestion. Results indicated that only
about 50% of His6-GFP-TEV-preRumA∗ complexed with His6-
RumM was digested by TEV whereas the same construct
not complexed with His6-RumM was completely digested
(Figure 9A). This partial susceptibility to TEV suggests possible
molecular interactions between His6-RumM and the precursor
peptide preRumA∗ fused to the C-terminus of GFP, since such
interactions may possibly shield the cleavage site that links the
two and render it inaccessible to TEV.
Partial resistance to TEV cleavage may be as a result
of cooperative/noncooperative interactions between His6-GFP-
TEV-preRumA∗ and His6-RumM as demonstrated by Khusainov
and colleagues for the class I lanthipeptide precursor NisA and its
modifying enzyme NisB (Khusainov et al., 2011). If His6-GFP-
TEV-preRumA∗ and His6-RumM were to interact cooperatively,
both the core segment and the leader segment of preRumA∗
would distinctively bind to His6-RumM at the same time, and
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FIGURE 7 | Product ions derived from the fragmentation of the C-terminal core peptide of preRumA∗. This figure describes the possible cross-linked structures that
gave rise to the product ions identified in the mass spectrum. The charges and measurement precisions in parts per million (ppm) are also indicated.
if noncooperative, either one of them would bind. This makes
sense because the functions of RumM are similar to that of
NisB, with an additional cyclase function which NisB does not
perform. This mode of interaction may be used to explain
the current observation since noncooperative interaction with
the core peptide alone may allow TEV to gain access to the
cleavage site as the site is located upstream of the leader peptide.
However, noncooperative interaction of RumM with the leader
sequence alone, or a cooperative mode which involves both
segments may bury the TEV site and render it inaccessible
to cleavage. Note that the interactions are not stable and so
the sequential bind/release cycles may contribute to slow down
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FIGURE 8 | Iodoacetamide derivatization and trypsin cleavage of preRumA∗. (A) Iodoacetamide reaction with the sulfhydryl group of cysteine side chain.
(B) Schematic representation of preRumA∗ showing five different fragments expected from the tryptic digestion. (C) Charged ions peaks observed in the Orbitrap
Fusion nLC-MS spectrum of the digested preRumA∗ products. The predicted exact masses for each of the fragments are labeled in their respective spectra.
(D) MS2 experiments and assignment of trypsin-activated RumA fragment ion peaks. Major product ions in the spectrum were identified to fit successive loss of
Gln18, Trp17 and Dhb16. (M’ +3H)3+ = 892.40∗.
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FIGURE 9 | TEV cleavage analyses and Native PAGE. (A) SDS-PAGE analysis of gel filtration-purified His6-RumM/His6-GFP-TEV-preRumA∗ complex (lane 1), free
His6-GFP-TEV-preRumA∗ (lane 2), TEV digest of complex (lane 3) and TEV digest of free His6-GFP-TEV-preRumA∗ (lane 4). (B) Native PAGE analysis of purified
His6-GFP-TEV-preRumA from WLEOgrA∗ strain (lane N1) and the His6-RumM/His6-GFP-TEV-preRumA complex sample (lane N2). Lane N2 shows multiple bands
above the expected molecular weight of His6-RumM corresponding to 1 or 2 molecules of His6-GFP-TEV-preRumA∗ complexed to one molecule His6-RumM.
the activity of TEV (see last paragraph of the “Discussion”
section).
To further verify if there was indeed a complex formation
between His6-RumM and His6-GFP-TEV-preRumA∗, a
sample was obtained from the His6-RumM/His6-GFP-
TEV-preRumA coeluted fraction and analyzed with native
PAGE, together with purified His6-GFP-TEV-preRumA∗
from WLEOgrA∗ strain employed as a control. The usual two
bands obtained for construct purified from WLEOgrA∗ or
WLEOgrA (Supplementary Information section “Purification
and TEV Cleavage of preRumA∗”) was visibly apparent whereas
four distinct bands belonging to His6-GFP-TEV-preRumA∗,
His6-RumM and complexes with molecular weights above
that of RumM were present in sample obtained from His6-
RumM/His6-GFP-TEV-preRumA coeluted fraction (Figure 9B).
It is unlikely that these were just mere aggregation since gel
filtration fractions (that were extensively diluted) still contained
these complexes (Supplementary Figure S5A). Result here
shows that the interactions are reversible since His6-RumM
and His6-GFP-TEV-preRumA∗ bands were also visible. The
outcome further suggests that the complex formation may have
occurred between His6-RumM and dehydrated preRumA∗ since
extracted preRumA∗ from the TEV digests all contained fully
cyclized product, and Mavaro et al. (2011) already demonstrated
that the interaction between modifying enzyme and dehydrated
precursor peptide has the highest affinity (Mavaro et al., 2011).
Bioassay Analysis of Trypsin Activated
His6-SUMO-preRumA∗
Using GFP as a fusion partner may also compromise the
overall yield of the final product because GFP itself is about
five times larger than the precursor peptide preRumA. To
mitigate this effect, we tested another fusion partners like
the SUMO. Two plasmids were designed to fuse preRumA∗
to SUMO (Supplementary Figure S1). Purified His6-SUMO-
preRumA∗ from the two strains WLEOsrA∗ (expressing
His6-SUMO-preRumA∗) and WLEOsrA∗M (expressing
His6-SUMO-preRumA∗ and His6-RumM) were digested
with trypsin (Figure 10A). His6-SUMO-preRumA∗ digest
from the latter strain was expected to yield putative mature
ruminococcin-A. The digested products were pipetted into wells
created in an agar plate spread with B. subtilis ATCC 6633 and
subsequently incubated at 30◦C overnight. A distinct zone of
inhibition was visible for the modified His6-SUMO-preRumA∗
construct and none for the unmodified construct as well as
trypsin digestion buffer that was used as a control (Figure 10B)
suggesting that only the modified product has growth inhibitory
biological activity. Additionally, the tryptic digest obtained
from the in vitro activation of preRumA∗ (derived from
WLEOgrA∗M1) was also pipetted onto an agar plate spread with
B. subtilis ATCC 6633. A distinct zone of inhibition was observed
(Figure 10C), suggesting that the isolated peptide also possessed
growth inhibitory biological activity against B. subtilis ATCC
6633.
Although we did not characterize products obtained from the
SUMO-fused constructs, being able to observe growth inhibitory
activity in extracts isolated from a system expressing both
preRumA and RumM and no activity in those isolated from the
system expressing preRumA alone, allowed us to conclude that
the SUMO fusion construct is also functional.
DISCUSSION
In the present study, we have shown that fusing the structural
gene for the precursor peptide preRumA to the gene encoding
the fast folding GFP and co-expressing the chimeric construct
simultaneously with the ruminococcin-A lanthionine synthetase
RumM resulted in the biosynthesis and modification of the
peptide in vivo. These results demonstrate that in a heterologous
host like E. coli, a larger attachment to the N-terminus of leader
peptide does not obstruct in vivo processivity of RumM in
catalyzing formation of PTMs in the core peptide of preRumA.
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FIGURE 10 | In vitro trypsin activation of His6-SUMO-preRumA and bioassay. (A) SDS-PAGE analysis of IMAC-purified modified His6-SUMO-preRumA∗ (lane 1),
trypsin-digested modified His6-SUMO-preRumA∗ (lane 2), IMAC-purified non-modified His6-SUMO-preRumA∗ (lane 3) and trypsin-digested non-modified
His6-SUMO-preRumA∗ (lane 4). (B) Bioassay analysis of the trypsin digested products of modified and non-modified His6-SUMO-preRumA∗ against B. subtilis
ATCC 6633 grown on a culture plate. (C) Mass spectrum showing prominent ion peak corresponding to active RumA purified from the trypsin digest of cyclized
preRumA∗ and bioactivity of the resulting product.
To the best of our knowledge, this is the first illustration which
demonstrate that the precursor peptide can still be correctly
modified with such a large fusion partner attached to the
leader sequence. This therefore provides an alternative approach
to derive some insights into mechanistic events underlying
the generation of MeLan/Lan rings as well as dehydroamino
acid in lanthipeptides. Thus the system developed herein has
potentials to be utilized in a subsequent study as a tool to
gain more insights into the catalytic mechanisms of LanM
enzymes.
We were able to obtain approximately 6 mg of modified
preRumA∗ per litee of E. coli culture (Table 2). Considering
the size ratio of leader-to-core segment (∼1:1.02), this amount
may be factored down to approximately 1–2 mg of pure and
active ruminococcin-A per liter of culture if the leader peptide
is removed. The nature of R. gnavus E1 poses several production
challenges with respect to growth and optimization. Dabard et al.
(2001) only succeeded in achieving a yield of 0.665 µg of RumA
per liter of R. gnavus E1 culture (Dabard et al., 2001). The specific
activity of RumA would have been a more appropriate parameter
to describe the quality of the expression and purification
procedures. However, the main focus of this study was first
to show that it is possible to produce this peptide in E. coli,
characterize its structure, show that it is active and then set
the platform for strain optimization. Additionally, TEV cleavage
released the fully modified precursor but not the active product.
The product only becomes active once the leader peptide is
removed. Our strategy to remove the leader peptide involved the
use of trypsin. There are three active trypsin cleavage sites in
preRumA∗ and therefore, a trypsin cleavage reaction will result
in a mixture of four different fragments from which to isolate the
active RumA. Further investigations would include introducing
a unique cleavage site (e.g., Factor Xa) between the leader and
the core segments to facilitate purification of the active product.
We made unsuccessful attempts to introduce a TEV cleavage site
at this position, probably because the cleavage sequence is too
long and so did not allow efficient modification of preRumA
by RumM. Nevertheless, activity against B. subtilis ATCC 6633
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FIGURE 11 | Proposed mechanism of Michael-type addition reaction catalyzed by RumM. (A) The C-terminus of the bifunctional enzyme possesses the conserved
residues that have been shown to coordinate Zn2+ ion in the active site of some lanthionine cyclase. The scheme illustrates the formation of the first N-terminal
lanthionine ring of RumA. (B) Highly conserved domains of selected lanthionine cyclases. The underlined residues are responsible for coordinating the central Zn2+
ion as shown in the crystal structure of NisC described earlier (Li et al., 2006; Li and van der Donk, 2007). The residues indicated by arrows are essential for an active
modification of subtilin, whereas those indicated by single orbitals appear to have no effect on SpaC catalytic activity (Helfrich et al., 2007). The conserved Gly
residues denoted by an open arrow was shown to be highly implicated in the maturation of epidermin (Agustin et al., 1992).
was observed in crude tryptic digests of preRumA∗ and His6-
SUMO-preRumA∗, which were enough to show that the peptide
is active.
It is also unlikely that regulating cultivation parameters and
engineering cultivation media would generate a meaningful
improvement with regards to product titres. Even if that would
be the case, the cost of production would be exceedingly high
with respect to the additional costs incurred by supplying trypsin
as a supplement to the cultivation medium. We have succeeded
to demonstrate that it is possible to produce RumA in E. coli
with higher yields, presenting an efficient strategy to consistently
develop a biotechnological process for the production of the
AMP. In fact, the numbers reported herein overwhelmingly
exceed the amount of RumA purified from the native host
in the order of 104, but comparatively lower with respect to
other reported cases (Shi et al., 2011, 2012; Tang and van
der Donk, 2012; Kuthning et al., 2015). However, this can
be improved by performing further optimization including
strain engineering or employing the use of smaller fusion
partners like SUMO or thioredoxin. Nevertheless, for the
purpose of studying peptide engineering and LanM catalysis,
the current system represents a perfect tool. Additionally,
other technologies which aim at expanding and/or increasing
antimicrobial activity of the compound, like the use of amber stop
codon suppression to incorporate non-canonical amino acids
into the peptide (Steiner et al., 2008; Chatterjee et al., 2012;
Oldach et al., 2012) may be easier to apply with the present
system.
With respect to structural characterization of modified
preRumA∗, data presented herein are consistent with those
obtained by Dabard and coworkers, with the exception of one
additional methyllanthionine ring between Thr7 and Cys12
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which was never reported. In fact, Dabard et al. (2001) concluded
in their study that the MeLan ring formation between these
two residues was not possible. Nevertheless, they arrived at this
conclusion using information derived from Edman degradation
assay. However, the Edman sequencing method is not very
accurate in studying the structure of lanthipeptides because of
limitations associated with the fact that any modification at the
N-terminus of the peptide sequence will block the experiment.
Additionally, Edman degradation is blocked by Lan/MeLan rings
as well as Dhb/Dha residues, and no sequence information
can be obtained thereafter (Lohans and Vederas, 2014). Based
on our mass spectrometry studies and data obtained from the
iodoacetamide derivatization reaction, we may conclude with
certainty that the structure described in Figure 6C represents the
actual structure of the modified precursor peptide. Additionally,
the third ring identified herein also constitutes the core active
feature referred to as the mersacidin-lipid II-binding motif which
is common in all class II lanthipeptides (Knerr and van der Donk,
2012).
This implies that in E. coli, the dedicated ruminococcin-A
lanthionine synthetase RumM is capable of catalytically installing
three thioether cross-linkages and one additional α,β-unsaturated
amino acid Into the core structure of preRumA. The dehydratase
domain of RumM catalyzes the dehydration of Thr7, Thr16, and
Thr22 to three Dhb, and Ser9 to Dha. Subsequently, the cyclase
domain engages in a Michael-type addition-cyclisation reactions
involving Dhb7 and Dhb22, and activated thiol groups of Cys12
and Cys24 to produce two MeLan rings, while the Dha9 and
Cys23 produce a Lan ring.
We hypothesize that RumM-catalyzed Michael-type addition
cyclisation reactions may follow the scheme proposed in
Figure 11A. The scheme is similar to the mechanism proposed
elsewhere for nisin cyclase (Li et al., 2006). Although low
sequence identity exist across the family members of lanthionine-
generating enzymes, the C-terminus of RumM possesses
conserved active site residues identical to those of nisin cyclase
(Figure 11B), indicating possible structure-function similarities,
and hence we postulate that their mode of action may be
closely similar. This type of structure-function similarity has been
described in a variety of the lanthionine-generating enzymes
(Knerr and van der Donk, 2012; Repka et al., 2017). The scheme
proposes that dedicated active site residues of the cyclase domain
of RumM may coordinate a hydrated Zn2+ cofactor whose water
molecule could be displaced by a cysteinyl thiol (e.g., Cys12 of
preRumA) which is targeted for conjugation with a Dhb/Dha in
the core peptide (e.g., Dhb7 of preRumA). By so doing, the thiol
group by itself may become activated, creating a nucleophilic
active center. The displacement of the water molecule or the
activation of the cysteinyl thiol may be facilitated by His778
which probably play the role of an acid/base catalyst like the
case of Tyr304 in SpaC (Helfrich et al., 2007). The electrophilic
carbon atom of the Dhb7 may now launch an attack on the
activated Cys12, forming an enolate intermediate which may
undergo subsequent protonation to generate the thioether cross
bridge (Figure 11A). Mutagenesis studies in conjunction with
mass spectrometry and/or bioassay analyses may be employed
to characterize the C-terminal domain of RumM, or perhaps
the crystal structure of the full-length enzyme may be more
resourceful.
In this study, we initially considered using two plasmids
to separately control the biosynthesis of the precursor peptide
preRumA and its modifying enzyme RumM. We considered
on the one hand that it was necessary to place rumM
under the control of a weaker promoter since its product is
larger (∼107 kDa) and thus may require more resources for
its biosynthesis and a slower process from transcription to
translation for the protein to be properly folded and soluble.
On the other hand, strong overexpression of the precursor
peptide may have little physiological effect on the host since
it is relatively small (5.34 kDa). As such, this strategy may
help to conceal the effects of cellular proteases on the small
peptide thereby increasing cellular availability of the unmodified
substrate and the chances for RumM to catalyze PTMs in
preRumA. It is challenging to say exactly why this strategy did
not generate the expected modifications in preRumA when His6-
preRumA was coexpressed with His6-RumM, although Basi-
Chipalu and coworkers employed a similar approach to modify
pseudomycoicidin in E. coli (Basi-Chipalu et al., 2015). We may
anticipate that the enhanced solubility (and no modification)
of preRumA in the strain WLEOrA/M would be facilitated
by a simple binding interactions between His6-preRumA and
His6-RumM since interactions between non-modified peptide
precursor and its modifying enzyme have been reported (Lubelski
et al., 2009; Khusainov et al., 2011; Mavaro et al., 2011; Repka
et al., 2017).
Furthermore, a mixture of modified and non-modified
preRumA were identified in extract obtained from strain
WLEOgrA/M (Supplementary Figures S4C,D) and the presence
of non-modified preRumA was not apparent in extract from
strain WLEOgrA (expressing His6-GFP-TEV-preRumA alone),
but rather truncated products (Supplementary Figures S4A,B).
These outcomes enabled us to reason that RumM may have
fostered some form of molecular interactions that in turn
conferred a stabilizing role on the precursor peptide since it is
believed that the enzyme forms a complex with the precursor
peptide (Lubelski et al., 2008, 2009). Data also exist, suggesting
a constant interaction with both the non-modified and the
modified substrate (Yang and van der Donk, 2015). These results
further supported our hypothesis that biophysical interactions
between His6-preRumA and His6-RumM may have facilitated
the solubility of the former without necessarily introducing the
desired modifications in the peptide. Nevertheless, mixtures of
partially dehydrated products are possible since investigations
revealed that the coupling of cysteinyl thiol to Dha/Dhb can
prevent further modification of serine and/or threonine residues
(Kuipers et al., 2008; Lubelski et al., 2009). We cannot at this time
report whether the intermediate products observed contained
at least one of the rings or not. Nevertheless, our results show
that low levels of RumM may have been responsible for the
inefficiency of strain WLEOgrA/M.
The amount of enzyme produced by the weakly expressing
vector may not be optimal for complete modification of
the precursor peptide to be achieved, which may explain
why unmodified preRumA was identified in extract from the
Frontiers in Microbiology | www.frontiersin.org 18 July 2018 | Volume 9 | Article 1688
fmicb-09-01688 July 24, 2018 Time: 19:0 # 19
Ongey et al. Biosynthesis and Characterization of Ruminococcin-A
WLEOgrA/M strain. This appeared to be the case as this
drawback was mitigated by reengineering the host vector to
favor adequate production of RumM. It is important to note
that applying the single-plasmid bicistronic expression vector
system did not improve the quality of His6-GFP-TEV-preRumA
when RumM was expressed under the control of the CU
promoter and RBS from the lactose operon (data not shown).
However, by replacing the RBS from the lactose operon with
that of gene 10 of bacteriophage T7, RumM expression was
enhanced and the degradation problem was solved. In fact, the
strain WLEOgrA∗M1 produced only minute traces of threefold
dehydrated peptide and no unmodified peptide compared to
strain WLEOgrA/M (Supplementary Figure S8). Therefore, it
is important to ensure adequate expression of the modifying
enzyme when trying to develop a combinatorial system for the
production of lanthipeptides in E. coli.
The interactions observed between His6-GFP-TEV-
preRumA∗ and His6-RumM may be further investigated
to supply more insights into the nature of complexing.
Crystallization experiments may be worthwhile to characterize
these complexes, which may reveal some structural features
in LanM enzymes yet to be known. Our data suggests that
dehydrated preRumA∗ may be predominant in the His6-GFP-
TEV-preRumA∗/His6-RumM complex since it has been reported
that the dehydrated precursor peptide binds the modifying
enzyme with highest affinity compared to the active and the
unmodified forms (Mavaro et al., 2011). Supposing that the
interactions between the precursor peptide and the modifying
enzyme does not form a stable complex, and the fact that a LanM
enzyme was recently shown to catalyze reversible opening of
the thioether rings (Yang and van der Donk, 2015), two key
points may be highlighted in the present case. (1) RumM may
slowly catalyze ring opening of the fully cyclized preRumA∗
thereby supplying the dehydrated precursor to the reaction
milieu. (2) Since the formation of thioether ring is an exergonic
process that favors closed-ring conformations in the peptide over
the opened-ring forms (Krenske et al., 2011), the dehydrated
precursor may immediately form a complex with RumM to
facilitate thioether ring formation again. Whether or not the
reaction medium can permit this is left for further investigation.
Nevertheless, the fact that preRumA∗ extracted from the TEV
digests all contained thioether rings indicated that majority of
the cleavage product was the fully cyclized peptide—the active
peptide essentially shows negligible binding affinities to the
enzyme as demonstrated by Mavaro et al. (2011).
CONCLUSION
In this study, we succeeded in producing fully modified
ruminoccin-A in E. coli. The modified precursor preRumA∗
(containing a Gly-1/Arg mutation) was activated in vitro by
cleaving off the leader peptide using trypsin. In vivo bioactivity
against B. subtilis ATCC 6633 was achieved using crude tryptic
digests of preRumA∗. Structural and molecular characterization
supplied further insights into the nature of modifications in
RumA and the mode of catalysis involving LanM enzymes.
We show that mature RumA contains three lanthionine cross
bridges instead of two as previously reported. We achieved
approximately 6 mg of modified preRumA per liter of E. coli
culture, which corresponds 1–2 mg of final active product, a yield
improvement of about 104 compared to yields obtained from the
native producer (Dabard et al., 2001). The system developed in
this work offers an irrefutable advantage over the native producer
in that the essential genes can be optimally controlled to allow
improved production. In a subsequent investigation, the systems
developed herein may be applied as a useful tool for mutagenesis
investigations and scale-up studies to achieve economic feasibility
since complicated and expensive experimental set-ups would not
be necessary.
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